Our commitment to sustainability

Telix has pledged a commitment to putting patients and its people first. Encompassed within this is an inherent sense of responsibility to all stakeholders, including the Company’s shareholders, and to minimise our impact on the environment as the organisation grows.

We understand the importance of integrating sustainability into all that we do in the delivery of our mission. We believe social purpose that puts people front and centre, ethical and good governance practices, performance, and responsibility to the environment are the foundations of sustainable value creation.

U.S. State Laws

Telix is committed to conducting its business in compliance with all state laws that may affect the marketing of our products and our relationship with healthcare professionals, and to this end has established and maintained a Comprehensive Compliance Program (CCP).

Below you will find a description of Telix State-specific program elements related to California’s Health and Safety Code §§ 119400-119402.

Telix Pharmaceuticals Annual Declaration of Compliance for Purposes of California Health & Safety Code §§ 119400-119402.

Telix US has developed a Comprehensive Compliance Program (“CCP”) that to the best of our knowledge is in material compliance with the California Health & Safety Code §§ 119400-119402. It is Telix US’ expectation that all employees comply with the Telix Code of Conduct and other applicable policies and procedures that can be found on the Telix Corporate Governance site. Telix US is continuously assessing and enhancing its CCP. Telix US asserts that as of February 28, 2024, its CCP is reasonably designed to identify or prevent and detect violations of applicable law, regulations and company policies or procedures. A copy of this Declaration may be obtained by emailing uslegal@telixpharma.com.

Telix is committed to conducting business with honesty and integrity. Telix takes all concerns related to the way it does business seriously, and rigorously investigates all credible issues brought to its attention. As part of this commitment, Telix protects from retaliation any person who raises a concern about the way that Telix does business. Telix has a dedicated external reporting hotline that includes the option for anonymous reporting (provided through Syntrio/Lighthouse)through the following options:

• Via a webform: www.lighthouseservices.com/Telixpharma

• By phone: English (US/Canada) 1-833-214-1164; Spanish (US/Canada) 1-800-216-1288; French (Canada) 1-855-725-0002; Spanish (Mexico) 01-800681-5340; All other countries +1-833-214-1164